Vycor Medical Inc
VYCO· OTC
Released Apr 16, 2024, after the close
10-K filed Apr 16, 2024, 107 days after period end · 0001493152-24-014837
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $308.25K | $271.26K | $273.72K | $291.62K |
| Net Income | -$93.06K | -$116.55K |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$187.06K |
| -$200.36K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.